We aimed to explore the effect of curcumin on epidermal stem cells (ESCs) in regulating wound healing and the underlying molecular mechanism. We treated mouse ESCs isolated from skin tissues with curcumin, and then assessed the proliferation ability of cells induced by epidermal growth factor using cell counting kit-8 assay. The pluripotency of ESCs was evaluated as well through examination of Nanog expression in ESCs. Further, mice with skin burns were treated with ESCs with or without curcumin pretreatments. Histological evaluations were then preformed to determine wound scores, cell proliferation, reepithelialization, and capillary density in wounds.
| INTRODUCTION
Stem cell therapy has been recently reported for treatments of burn wound. For instance, mesenchymal stem cells (MSCs) are capable of differentiation into epidermal cells or skin appendages including sebaceous glands and sweat glands, which demonstrate the potential in burn treatment. Studies in recent years showed that stem cell transplantation, either systemic or local, promoted wound healing of injured skin, transformation of endothelial cells, as well as vascular formation, and thereby exerting curative effects against skin damage (Kanji & Das, 2017) . Nevertheless, investigations also demonstrated that treatment with simple transplantation of stem cells cannot guarantee satisfactory skin wound healing. Therefore, research exploring the mechanism underlying the protective effects of stem cells on skin wound healing is needed.
Curcumin, also known as diferuloylmethane or 1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione, is a low-weight lipophilic molecule. During the past decades, extensive studies have shown that curcumin alters gene expression, modulates various signal transduction pathways, and produces numerous health benefits including anti-inflammatory effects (Mantzorou, Pavlidou, Vasios, et al., 2018; Pagano, Romano, Izzo, et al., 2018) . A number of investigations reported therapeutic effects of curcumin on wound healing † Ronghua Yang and Jingru Wang contributed equally to this work. (Mohanty & Sahoo, 2017) . Recent researches have showed that curcumin accelerated wound healing via multiple biological actions (Emiroglu, Ozergin Coskun, Kalkan, et al., 2017; Yen, Pu, Liu, et al., 2018) . In another report using a mouse model with fractionated irradiation exposure-induced full-thickness wounding, orally administered curcumin for 5-20 days enhanced collagen synthesis, increased fibroblast and vascular densities, and improved contraction by reducing healing time in a dose-dependent manner (Jagetia & Rajanikant, 2012) . Particularly, a recent study indicated that curcumin was able to upregulate caveolin-1 expression by stabilizing it (L-n, Z-x, X-c, et al., 2014) .
It has been recently shown that epidermal stem cells (ESCs) exert critical functions in the healing process of skin wound (Wang, Shu, Xu, et al., 2017) . Among potential mechanisms mediating such process, caveolin deserves further study. Caveolin have three main subtypes, namely, caveolin-1, −2, and −3, of which caveolin-1 is an integral membrane protein ubiquitously expressed by different types of cells (Williams & Lisanti, 2004) . Early reports suggested that caveolin-1 may be primarily involved in the transmembrane transport; however, more recent investigations showed that caveolin-1 could also interact with various proteins and act as a hub for signalling molecules (Fridolfsson, Roth, Insel, et al., 2014) . A number of signalling molecules could interact with caveolin-1 at its scaffold region to be negatively modulated. In addition, caveolin-1 may also be involved in the regulation of calcium channels. Given that the proliferation as well as directed differentiation of stem cells is controlled by a variety of signal transduction pathways including calcium signalling; it is highly likely that caveolin-1 is involved in the regulation of stem cells. Indeed, several recent investigations found that in many different types of cells, caveolin-1 enhanced the ability of directed differentiation (Codenotti, Vezzoli, Poliani, et al., 2016) , and in particular, caveolin-1 was reported to modulate the differentiation fate of stem cells such as interstitial stem cells (Wang, Kan, Sun, et al., 2013) and neural stem cells (Li, Lau, So, et al., 2011) . Therefore, in this study, we speculated that curcumin could promote the physiological functions of ESCs by regulating caveolin-1 expression, and consequently accelerate wound healing.
| MATERIALS AND METHODS

| Isolation of mouse ESCs
Skin tissues were dissected from the back of mice and cut into small pieces (approximately 0.3 × 0.3 cm 2 ), then incubated overnight at 4°C in phosphate buffered saline (PBS) containing 0.5% dispase II (17105041; Gibco, Grand Island, NY). The epidermal sheets were then carefully separated from the dermis and digested in 0.25% trypsin (25200-056; Gibco, Grand Island, NY) for 20 min at 37°C. Dulbecco's modified Eagle's medium (12100-046; Gibco, Grand Island, NY) containing 10% fetal bovine serum was added at the end to terminate the digestion. Samples were then filtered and centrifuged. Cell were resuspended in keratinocyte serum-free medium (K-SFM, 17005042;
Gibco, Grand Island, NY), and subsequently seeded in precoated flasks (coated with 100 μg/mL collagen IV, ab6586; Abcam, Cambridge, MA, United States) at a density of 105 cells/cm 2 . Cells were allowed to adhere for 15 min at 37°C, and the adhering cells were collected and cultured in K-SFM medium in 5% CO 2 at 37°C. At 70%-80% con- 
| Establishment of ESCs with stable knockdown of caveolin-1
Lentiviral shRNA construct against mouse caveolin-1 (SHCLND-NM_007616) was purchased from Sigma-Aldrich and used to transduce mice ESCs following manufacturer's instructions.
| Western blot
The cells were lysed in ice-cold RIPA lysis buffer, and the protein concentration was determined using the BCA protein assay kit (ThermoFisher, Waltham, MA, United States) following the provided manual. Total protein was run on the SDS-PAGE gel and transferred onto the polyvinylidene difluoride membrane on ice (300 mA, 2 hr).
The membrane was then blocked with 5% nonfat milk dissolved in the TBST buffer for 1 hr at room temperature, and incubated with the primary antibodies (caveolin-1, ab2910, 1:1000; GAPDH, ab9485, 1:2000), both purchased from Abcam, overnight at 4°C. After vigorous washes with TBST (6 × 5 min), the membrane was subjected to incubation with the horseradish peroxidase-conjugated secondary antibody for another hour at room temperature. Visualization of the final blots was performed using the enhanced chemiluminescence kit (ECL, Millipore, Billerica, MA, United States).
| Animals
Adult BALB/c mice (male and female) were purchased from Shanghai 
| Mouse model of burn injury
The mouse model of cutaneous burn injury was established as previously described with minor modifications (Zhu, Wei, Bian, et al., 2008) . We anesthetized mice with 1% pentobarbital (30 mg/kg) and shaved the hair on the back. A copper plate tip (10 × 10 mm 2 ) was attached to a 40 W soldering iron and connected to an electronic temperature controller to precisely monitor the temperature. To induce the burn injury, the copper plate tip was heated to 100°C, and then applied to the mouse skin for 10 s, immediately followed by application of gauze that was preembedded in 22°C isotonic saline to cover the wound (Calum, Høiby, & Moser, 2014 water. Analgesia (30-mg codeine phosphate in 500-mL tap water) was provided after burn injury for 24 hr. Photographed images were used to record wound healing, and digital planimetry was employed to determine wound area using ImageJ software (NIH, Bethesda, MD, United States). Wound score and wound closure rate were then calculated using previously established methods (Shi, Shu, Yang, et al., 2015) .
| Histological analysis
Skin tissue samples were harvested at Postinjury Day 7, fixed using formalin, embedded in paraffin, and sectioned at 4-μm thicknesses.
Sections were then deparaffinized and subjected to hematoxylin and eosin (H&E) staining. Standard light microscopy (OLYMPUS, Japan) was utilized to assess H&E staining. Wound scores ranging from 1 to 10 were given to each slide.
| Statistical analysis
We analysed all data with PRISM 5.0 software (GraphPad, CA, United States). Values were presented as the mean ± standard deviation (SD).
Since there was no statistical difference in all data analysis between male and female groups, we pooled data from male and female groups together. Student's t test was employed to determine the difference between control and experimental groups. One-way analysis of variance (ANOVA) or multifactorial ANOVA was applied for comparison between multiple groups. A Bonferroni post-hoc test for pairwise comparisons was performed wherever appropriate. p values less than 0.05 indicated statistical significance.
3 | RESULTS
| Curcumin treatment promotes the proliferative ability of ESCs
The proliferation capability of ESCs treated with curcumin was similar to the vehicle control without EGF treatments. However, after EGF treatments, it was observed that curcumin promoted the proliferation of ESCs compared with the vehicle control (treatment main effect, p < 0.01; Figure 1a ). Further, we found that treatments with curcumin in ESCs stimulated ESC proliferation in comparison with the control ESCs (ESC and treatment interaction effect, p < 0.05; Figure 1a ). In order to evaluate the effects of curcumin on ESC pluripotency, we assessed the changes of Nanog mRNA levels induced by curcumin during the differentiation process of ESCs induced by EGF. We found that the expression of Nanog mRNA reduced overtime (Figure 1b) .
Further, treating ESCs with curcumin did not alter Nanog expression compared with control ESCs (Figure 1b ). 
| Curcumin treatment elevates caveolin-1 expression in ESCs
Since curcumin was reported to upregulate caveolin-1 (L-n et al., 2014), which regulates the differentiation of stem cells (Li et al., 2011; Wang et al., 2013) , we next sorted to verify this effect in isolated ESCs. Indeed, both mRNA and protein levels of caveolin-1 were significantly elevated when the EGF-induced ESCs were treated with curcumin ( Figure 3a ,b, ESC + EGF and ESC + Cur + EGF). Naturally, we wondered whether caveolin-1 could be the factor mediating the beneficial effect of curcumin, in terms of ESC proliferation and FIGURE 1 Effects of curcumin treatment on epidermal stem cell (ESC) proliferation and differentiation. (a) ESCs were treated with epidermal growth factor (EGF; 0 or 10 ng/ml) and/or curcumin (0 or 10 μM) for 10 days and showed increased proliferation. (b) ESCs were treated with 10 ng/ml EGF and curcumin (0 or 10 μM) for 10 days, and the differentiation potential was not altered. Values were presented as the mean ± SD from at least three independent experiments. * p < 0.05, compared with vehicle control (ESC). # p < 0.05, compared with ESC and ESC + EGF group 
| Caveolin-1 is required for the beneficial effect of curcumin on ESC proliferation and HUVEC tube formation
We next examined the effect of caveolin-1 knockdown on ESCs.
Notably, caveolin-1 knockdown had no effect on Nanog expression Histological assessments were then conducted at Postinjury Day 7, when robust skin closure was usually observed. We discovered enhanced reepithelialization in wounds treated with ESCs compared FIGURE 3 Curcumin treatment elevates caveolin-1 expression in epidermal stem cells (ESCs). ESCs, with or without caveolin-1 knockdown (KD), were treated with 10 ng/ml epidermal growth factor (EGF) and/or curcumin (0 or 10 μM) for 10 days, followed examination of caveolin-1 mRNA (a) and protein (b) expressions. Values were presented as the mean ± SD from at least three independent experiments. * p < 0.05, compared with both ESC + EGF and ESC-KD + Cur + EGF Moreover, we also examined the expression of angiogenic marker CD31 at the wound site, and found its expression corresponded with the wound close scores (Figure 6c ).
| DISCUSSION
In the current study, we investigated the effect of curcumin on ESCs during the process of wound healing. We first isolated ESCs from mouse skin tissues and treated them with curcumin. We found that curcumin treatment of ESCs promoted EGF-induced cell proliferation, and no change in Nanog mRNA expression level was observed in the treated ESCs, indicating that curcumin did not affect the pluripotency of ESCs. Further, incubation of HUVEC with medium containing curcumin enhanced tube formation, suggesting a paracrine effect of ESC on angiogenesis. Based on the results from in vitro experiments, we treated mice with skin burn injuries using ESCs with or without curcumin pretreatment. We found that in mice received curcumintreated ESCs, the wound closure was accelerated. Histological assessments also showed that curcumin-treated ESCs boosted Numerous investigations have shown that reepithelialization is necessary for restoration of the epidermis during the burn wound healing (Rousselle, Montmasson, & Garnier, 2018) . Our results showed that ECSs exert important functions in promoting reepithelialization during this process. ESCs, which are found in in the basal layer of the epidermis and the follicle bugle of hair, possess prominent potential of proliferation and differentiation (Charruyer & Ghadially, 2011) .
Under physiological conditions, ESCs play pivotal roles in maintaining the normal structure and function of skin, as well as in wound repairing through proliferation, differentiation, and migration (Blanpain & Fuchs, 2009) . Following this line of research, our findings demonstrated that upregulation of caveolin-1 by curcumin treatment in ESCs is associated with reepithelialization following skin wound injury.
Indeed, prior studies have shown that lack of caveolin-1 was involved in the abnormal reepithelialization in lung fibrosis (Odajima, Betsuyaku, Nasuhara, et al., 2007) . Thus, future investigations are needed to explore the specific mechanisms mediating such phenomenon.
Caveolin-1 is involved in the proliferation of differentiated cells as well (Baker & Tuan, 2013) . It has been reported that, in caveolin-1 null mice, higher numbers of cells expressing markers for stem cells were observed in several organs including gut, brain, and mammary gland (Jasmin, Yang, Iacovitti, et al., 2009; Sotgia, Williams, Cohen, et al., 2005) , suggesting that caveolin-1 may exert negative modulation of stem cell proliferation. Further, it was shown that caveolin-1 facilitated glucocorticoid receptor signalling, which lead to suppressed proliferation of mouse neural progenitor cells (Samarasinghe, Di Maio, Volonte, et al., 2011) . Additionally, higher proliferative rate of bone marrow-derived MSCs was observed in cultures isolated from the caveolin-1 null mouse (Case, Xie, Sen, et al., 2010) . In a similar manner, the proliferative rate of human MSCs was reported to be inversely associated with the expression level of caveolin-1 (Park, Kim, Kim, et al., 2005) . Finally, knockdown of caveolin-1 with siRNA enhanced the proliferation of human MSCs (Baker, Zhang, You, et al., 2012) .
However, in contrast to these previous reports, our data suggested that the expression level of caveolin-1 in the ESCs was positively correlated with the proliferation ability. In fact, it has also been reported that treating mouse embryonic stem cells with caveolin-1 siRNA decreased the cell proliferation index (Lee, Ryu, Lee, et al., 2010) , and that caveolae integrity and caveolin-1 phosphorylation were required for downstream regulation of DNA synthesis in embryonic stem cells (Park, Ryu, & Han, 2011) . Taken together, results from our study and others implied that the specific function of caveolin-1 in the regulation of stem cell proliferation may be associated with complex signalling pathways in different types of stem cells.
Ample evidence has illustrated that cell differentiation often involves upregulated expression of caveolin in vitro (Fuchs, Hollins, Laue, et al., 2003; Liu, Wang, Park, et al., 2001; Ng, Ramsauer, Loureiro, et al., 2004) , indicating that caveolin expression inhibits cell differentiation. For instance, bone marrow MSCs displayed greater osteogenic potential in caveolin-1 null mice (Rubin, Schwartz, Boyan, et al., 2007) . Caveolin-1 knockdown also potentiated human MSC osteogenesis (Baker et al., 2012) and adipogenesis (Park et al., 2005) , as well as neuronal differentiation in rodents (Li et al., 2011; Wang et al., 2013) . Surprisingly, our data of Nanog mRNA levels showed that in ESCs caveolin-1 overexpression may not alter the differentiation potential of ESCs after treatment of EGF. While other markers for stem cell differentiation were not examined, it is also possible that different signalling pathways may be at work in different stem cells. For example, rat MSC differentiation is modulated by caveolae endocytosis of bone morphogenetic protein receptors (Du, Chen, Liang, et al., 2011) , and in caveolin-1 null mice, active β-catenin levels were observed in cells expressing stem cell markers in both intestinal crypts and mammary gland (Li, Hassan, Williams, et al., 2005; Sotgia et al., 2005) . On the other hand, regulation of neurogenesis by caveolin1may be mediated through Notch signalling (Wang et al., 2013) . ESCs could reportedly improve diabetic wound healing by promoting cell migration through the Notch signalling pathway (Yang, Qi, Shu, et al., 2016) . Therefore, future studies examining whether caveolin-1 expression alters Notch signalling in ESCs are necessary.
Increasing body of literature supported the effects of curcumin in treating various wound types, and its great therapeutic potential (Mohanty & Sahoo, 2017; Tejada, Manayi, Daglia, et al., 2016; Vaughn, Haas, Burney, et al., 2017) . For example, in a rat burn model, curcumin was found to attenuate injury progression as indicated by the proportion of necrotic unburned interspaces (Singer, Taira, Lin, et al., 2011) .
Siddu et al. also reported that oral and local administration of curcumin accelerated healing in diabetic mice with full thickness skin wounds, an effect mediated via elevated production of TGF-β at both the protein and transcript levels (Sidhu, Mani, Gaddipati, et al., 1999) .
In addition, improved epithelial regeneration at the wound site was observed in curcumin-treated animals. These data are consistent with observations in our current study, where curcumin exhibits beneficial effect not only in vitro on ESC proliferation and HUVEC tube formation but also in vivo on ESC-mediated treatment against burn wound.
Besides, curcumin is nonmutagenic and nongenotoxic for human especially in oral administration (Soleimani, Sahebkar, & Hosseinzadeh, 2018) , making it an ideal clinical candidate of therapy against skin wounds.
To summarize, our findings suggested that treatments with curcumin enhanced caveolin-1 expression in ESCs, and thereby enhancing ESC proliferation potential. Modifications of ESC proliferation potential may serve as an effective approach to accelerate cutaneous wound healing. Further, it is equally important to improve the quality of wound recovery process by avoiding scar formation. Our recent work demonstrated that fibroblast growth factor reduced scar formation through suppressing the differentiation of ESCs into myofibroblasts. Thus, using combinational approach with multiple growth factors as well as manipulation of ESC proliferation potential, we may develop effective therapeutic options to improve the quality of skin wound healing.
